Hunter Perkins Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.38M Sell
64,818
-26,228
-29% -$3.07M 1.88% 14
2026
Q1
$11M Sell
91,046
-11,450
-11% -$1.32M 2.59% 9
2025
Q4
$10.9M Sell
102,496
-10,315
-9% -$968K 2.51% 8
2025
Q3
$9.56M Sell
112,811
-581
-0.5% -$47.9K 2.12% 12
2025
Q2
$9.07M Buy
113,392
+988
+0.9% +$78.5K 2.15% 14
2025
Q1
$10.2M Sell
112,404
-24,018
-18% -$2.24M 2.36% 12
2024
Q4
$13.7M Buy
136,422
+36,292
+36% +$3.74M 2.87% 9
2024
Q3
$11.4M Buy
100,130
+8,143
+9% +$967K 2.32% 15
2024
Q2
$11.4M Sell
91,987
-1,340
-1% -$173K 2.4% 13
2024
Q1
$12.4M Sell
93,327
-6,390
-6% -$788K 2.53% 14
2023
Q4
$10.9M Buy
99,717
+86,247
+640% +$8.95M 2.28% 16
2023
Q3
$1.39M Sell
13,470
-15,225
-53% -$1.64M 0.3% 56
2023
Q2
$1.42M Buy
28,695
+12,270
+75% +$1.39M 0.3% 64
2023
Q1
$1.75M Sell
16,425
-300
-2% -$32.4K 0.41% 48
2022
Q4
$1.86M Sell
16,725
-3,500
-17% -$358K 0.42% 42
2022
Q3
$1.75M Sell
20,225
-4,650
-19% -$415K 0.43% 45
2022
Q2
$2.27M Sell
24,875
-208,506
-89% -$18.5M 0.52% 36
2022
Q1
$19.1M Sell
233,381
-2,214
-0.9% -$175K 3.84% 8
2021
Q4
$18.1M Sell
235,595
-39,340
-14% -$3.13M 3.38% 11
2021
Q3
$20.6M Buy
274,935
+13,985
+5% +$1.06M 4.2% 5
2021
Q2
$20.3M Buy
260,950
+36,102
+16% +$2.69M 3.78% 10
2021
Q1
$16.5M Buy
224,848
+183,863
+449% +$13.6M 3.34% 10
2020
Q4
$3.2M Buy
+40,985
New +$3.13M 0.57% 38

Other funds holding MRK

Hunter Perkins Capital Management's MRK Position: Q2 2026 in Review

Hunter Perkins Capital Management reduced its Merck (MRK) stake by 29% in Q2 2026, selling an estimated $3.07M and leaving 64,818 shares worth $8.38M. The position accounts for 1.88% of the portfolio, ranked #14.

Hunter Perkins Capital Management first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $20.6M in Q3 2021. 1,552 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hunter Perkins Capital Management held 64,818 shares of Merck worth $8.38M as of Q2 2026.
  • Hunter Perkins Capital Management sold 26,228 Merck shares in Q2 2026, an estimated $3.07M.
  • Merck made up 1.88% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #14 holding.
  • Hunter Perkins Capital Management first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Hunter Perkins Capital Management's Merck position peaked at $20.6M in Q3 2021.
  • 1,552 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.